FOSUN HEALTH Logo

Esophageal Cancer FAQ

catalogue

Esophageal Cancer FAQ

Esophageal Cancer FAQ

The questions international patients ask most about esophageal cancer treatment: what drives the cost, how long the operation and recovery take, which records to send, how insurance is handled, and what eating is like afterwards.

What actually drives the cost

Three variables explain most of the difference between one quotation and another, and the first of them is whether an operation happens at all.

Whether an oesophagectomy is performed. It is a major operation through two or three compartments, with intensive care and a reconstruction, so the cost reflects the operating time, the lymph node dissection and post-operative care. A pathway ending in endoscopic removal, or in definitive chemoradiotherapy, costs substantially less — not lesser care, but different treatment.

Whether chemoradiotherapy is part of the plan, and how many weeks. Radiotherapy is given daily over several weeks with weekly chemotherapy, and the cost scales with the number of fractions and with the drugs used. Where treatment is given before an operation and continues afterwards, the total is larger than for a single phase.

Supportive and nutritional care. A stent, a feeding tube, dietetic support and the management of complications are individually modest but real parts of the total, and they are the items most often left out of an estimate made from a scan alone.

Comprehensive esophageal cancer treatment in China typically costs 30–50% of the equivalent treatment in Europe or the US, and the gap is widest in radiotherapy and drug therapy. We do not quote a number before there is a plan: the written assessment states what treatment is expected to involve — endoscopic removal, chemoradiotherapy then surgery, or definitive chemoradiotherapy — and the cost follows from that. Sending your records costs nothing.

How long treatment takes, and how long to stay

Oesophageal cancer treatment is measured in months, and the practical planning depends on which pathway applies.

  • Neoadjuvant chemoradiotherapy — several weeks of daily treatment as an outpatient, then a restaging interval before the operation. Plan on staying for the whole course rather than travelling in between.
  • The operation — the hospital stay after an oesophagectomy is commonly around two to three weeks, and longer if a leak from the join or a respiratory complication occurs.
  • Recovery before further treatment — several weeks at home focused on eating, weight and walking, since the ability to eat determines what further treatment is possible.
  • Adjuvant treatment — where a PD-1 inhibitor is given after chemoradiotherapy and surgery, it runs in cycles over months and can usually be continued after returning home against a written plan.
  • Definitive chemoradiotherapy — several weeks of daily radiotherapy with weekly chemotherapy, followed by restaging rather than a long additional stay.
  • Endoscopic treatment — a submucosal dissection usually means one to two nights in hospital, which is the shortest pathway of all.

The one thing worth planning around is the post-operative stay. It is longer than patients expect, so arrange accommodation and visa duration for more than you think you need.

Chemotherapy, feeding and what travels home

Which items can be continued at home and which cannot shapes how the end of a treatment period is planned:

  • Oral nutrition and supplements travel home and continue indefinitely, and are part of the treatment rather than an optional extra.
  • Feeding tube feeds can be continued at home where the local service supports it, and patients can still eat by mouth alongside them.
  • Chemotherapy cycles can often be continued locally where the regimen and monitoring arrangements are agreed in advance, against a written protocol rather than improvised on return.
  • PD-1 inhibitor treatment given in cycles requires an infusion facility and monitoring, so it is arranged at a centre rather than at home.
  • Acid suppression and pain treatment travel home against a written plan, including what was used and what the alternatives are.
  • A stent needs follow-up — it can block or migrate, so arrangements for review or exchange should be made before leaving.

The general rule is that oral treatment, nutrition and a written plan travel; infusions and anything requiring monitoring after them do not.

What to send before you travel

Because the treatment route hinges on depth and type, the records that matter are specific, and a summary letter cannot substitute for any of them:

  • The endoscopy report with images — the distance from the incisors, the length, the appearance of the lesion, and whether chromoendoscopy was used.
  • The biopsy report with HER2, PD-L1 and mismatch repair results — if these were not requested originally, they can usually be added to the stored tissue.
  • The endoscopic ultrasound report — without the depth assessment, the choice between endoscopic treatment and surgery cannot be made.
  • CT of the chest and abdomen on disc, in DICOM format, plus any PET-CT and barium swallow.
  • Weight history and current intake — how much weight has been lost and what can still be swallowed, because this determines whether nutritional support is needed before treatment starts.
  • Current medication, particularly anticoagulants and acid suppression, and details of any stent already placed.

Where a test has not been done it can be arranged on arrival. Where a lesion appears early, the assessment should include a view on endoscopic treatment, because that option exists only while the tumour remains confined to the mucosa.

Insurance and payment

International patients arrive with very different arrangements, and the practical question is what can be settled before treatment begins.

  • Direct billing — the hospital network holds direct-billing agreements with a large number of international insurers, which allows treatment without paying upfront and claiming afterwards.
  • Pre-authorisation — most insurers require it before an oesophagectomy or a course of chemoradiotherapy, and the clinical documentation needed is the same set of records described above.
  • What to check — whether treatment abroad is covered at all, whether a second opinion is required before authorisation, and whether extended stay and repatriation are included.
  • What is usually excluded — travel, accommodation, nutritional supplements and the cost of a longer stay than planned are commonly outside insurance, and worth budgeting for separately.

The clinical summary an insurer requires is normally supplied with the written assessment — easier to request at the same time than once treatment has begun.

Follow-up after you go home

Follow-up continues indefinitely after treatment for oesophageal cancer, and its pattern follows what was done:

  • After endoscopic treatment — surveillance endoscopy at intervals, because a new lesion can develop elsewhere in a field that has already produced one.
  • After an operation — clinical review, blood tests and cross-sectional imaging on a schedule, usually more frequently in the first two years and less often afterwards.
  • Nutrition and weight — tracked deliberately, with attention to vitamin and mineral levels, since absorption changes after oesophagectomy.
  • Swallowing — any return of difficulty swallowing is assessed rather than assumed to be a benign narrowing, because it may indicate recurrence at the join.
  • What to report immediately — a new hoarse voice, coughing on swallowing, fever, chest pain, or vomiting blood.

Follow-up is provided as a written schedule naming the specific tests, so it can be carried out locally without ambiguity.

Eating after treatment

Eating is the practical concern patients raise most often, and it changes rather than ends. Both the operation and radiotherapy alter how food is swallowed, so planning ahead is more useful than reacting afterwards.

  • After oesophagectomy — the stomach replaces the oesophagus, so portions are smaller and meals more frequent. Eating slowly, chewing well and separating fluids from solids helps; lying down after eating does not.
  • After radiotherapy — the lining is inflamed during treatment and for some weeks after, so soft, moist food is easier. Most of this recovers, though narrowing at the treated site may need dilation later.
  • Nutritional supplements and vitamin monitoring — part of the follow-up plan, because absorption of iron, calcium and several vitamins changes after the stomach is repositioned.
  • Feeding tubes have a role — used during treatment or recovery without preventing eating by mouth, and removed when intake is adequate.
  • Dumping symptoms — some patients feel faint, sweaty or nauseated shortly after eating; this is manageable by changing meal size and composition, and should be reported rather than endured.

Two habits make the largest difference: eating small amounts often rather than large meals, and asking for dietetic input early rather than after weight has already fallen. Weight is a treatment variable here, not just a comfort measure.

Frequently Asked Questions

Will I be able to eat normally after an oesophagectomy?

Most patients can eat by mouth, but not in the same way as before. The oesophagus is replaced by a tube made from the stomach, which holds less, so meals are smaller and more frequent, and some foods are difficult. Eating slowly, chewing thoroughly and taking fluids between rather than with meals all help. It is a reconstructed swallow rather than a lost one, and patients who expect it to feel unchanged are the ones most disappointed — so it is worth planning the diet with a dietitian before the operation rather than after it.

Can I have treatment without surgery?

It depends on the depth of the tumour and on your general condition. A tumour confined to the mucosa can be removed through the endoscope with no operation at all. Alternatively, definitive chemoradiotherapy is a recognised pathway that avoids an operation, and it is the standard approach for tumours in the cervical oesophagus or for patients whose fitness makes surgery unsafe. What cannot be done is deciding this from the stage number alone — depth, spread and fitness all contribute.

How long will I need to stay in China?

It depends on the pathway. Neoadjuvant chemoradiotherapy runs for several weeks and is followed by restaging and then the operation, so the whole programme is typically two to three months including recovery. Definitive chemoradiotherapy is several weeks of daily treatment followed by restaging. Endoscopic submucosal dissection is the shortest, usually a night or two in hospital. An oesophagectomy itself means roughly two to three weeks in hospital and several further weeks before travelling comfortably.

Can I keep eating during chemoradiotherapy?

Many patients can, with changes — soft, moist, bland food, eaten slowly and in small amounts, often with supplements in between. The lining becomes inflamed during radiotherapy, so difficulty tends to increase through the course and improve afterwards. Where intake becomes inadequate a feeding tube is used so treatment can continue; it does not prevent eating by mouth. Weight and intake are monitored through the course.

Comparing a plan and a cost, rather than one or the other?

Send the endoscopy report, the biopsy with its HER2 and PD-L1 results, the endoscopic ultrasound report, the CT on disc and your insurance details. Our upper gastrointestinal team will return a written assessment within 48 hours of the file being complete, describing what the treatment is expected to involve and how eating will be managed along the way.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*